Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-04-26
2005-04-26
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
06884776
ABSTRACT:
The invention relates to the use of ubiquicidine or optionally modified peptide fragments derived therefrom for the preparation of a drug for the treatment, diagnostics or prophylaxis of infections in humans and animals. A peptide fragment derived from ubiquicidine comprises for instance a preferably continuous series of at least 3, preferably at least 7-13 amino acids from the amino acid sequence of ubiquicidine; KVHGSLARAGKVRGQTPKVAKQEKKKKKTGRAKRRMQYNRRFVNVVPTFGKKKGPN ANS (SEQ ID NO: 1). Hybrid molecules comprise for instance a cationic peptide with an antimicrobial action and/or a peptide fragment of ubiquicidine and/or a derivative thereof and one or more effector molecules.
REFERENCES:
patent: 6319503 (2001-11-01), Kenten et al.
patent: 08176193 (1996-07-01), None
patent: 08176193 (1996-07-01), None
English translation of JP 08176193 A.*
Olvera J, Wool IG. The carboxyl extension of a ubiquitin-like protein is rat ribosomal protein S30. J Biol Chem. Aug. 25, 1993;268(24):17967-74.*
XP-00205805, Nelson , Christopher A., et al., “Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-A”, Proc. Nat'l Acad Sci. USA, vol. 89 pp. 7380-7383, Aug. 1992, Immunology.
XP-002052804, Kas, Koen et al., “Genomic structure and expression of the human fau Gene: encoding the ribosmal protein S30 fused to a ubiquitin-like protein”, Biochemical and Biophysical Research Communications, vol. 187, No. 2, 1992, pp. 927-933.
Hiemstra, Pieter S., et al., “Antimicrobial Proteins of Murise Macrophages”, Infection and Immunity, vol. 61, No. 7. Jul. 1993, pp. 3038-3046.
Pauwels, E.K.J. et al., “The Labeling of Proteins and LDL wish”, Tc: a New Direct Method Employing KBH4and Stammous Chlorida, Nucl. Med. Biol., vol. 20, No. 7 pp. 823-833, 1993.
XP-002052807, Malcherek, Georg et al., “Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis”, Chemical Abstracts, vol. 120.
XP-002052808, Miyazaki, Toshiuki et al., “Basic proteins derived from wheat germs for treatment . . . ”, Chemical Abstracts, vol. 118.
de Kosser, H. Saskis et al., “The use of dedicated peptide libraries permits the discovery of high affinity binding peptides”, Journal of Immunological Methods, vol. 187, (1995) pp. 179-188.
Martin, Edith et al., “Defensins and other esdogenous peptide antibiotics of vertebrates”, Journal of Leukocyte Biology, vol. 58, Aug. 1995, pp. 128-136.
XP-002052806, Ridgway, William M. et al., “Breaking self-tolerance in nonobese diabetic mice”, Chemical Abstracts, vol. 124.
Feitsma Rolf Ide Johannes
Hiemstra Pieter Sicco
Nibbering Petrus Hendricus
Pauwels Ernest Karel Jacob
Van Den Barselaar Maria Theodora
Carlson Karen Cochrane
RijksUniversiteit Leiden
Snedden Sheridan K
Webb Ziesenheim & Logsdon Orkin & Hanson, P.C.
LandOfFree
Antimicrobial peptides derived from ubiquicidine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimicrobial peptides derived from ubiquicidine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial peptides derived from ubiquicidine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3399952